News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Ruben Mesa: Decreasing the Burden of Cancer in the Carolinas and Beyond
Feb 1, 2025, 17:41

Ruben Mesa: Decreasing the Burden of Cancer in the Carolinas and Beyond

Ruben Mesa, President of Atrium Health Levine Cancer Institute, shared on LinkedIn:

“Amazing passion, energy, purpose to decrease the burden of cancer in the Carolinas and beyond! Stellar 2025 Research Retreat of the Atrium Health Wake Forest Baptist Comprehensive Cancer Center, we leave energized to Change Cancer As We Know It through our cancer research, training and Cancer Care. “

cancer OncoDaily Oncology Ruben Mesa
Special Coverage
Blog
Feb 1, 2025, 17:41
Ruben Mesa: Decreasing the Burden of Cancer in the Carolinas and Beyond
Blog
Feb 1, 2025, 17:37
Celebrating 30 years of National Comprehensive Cancer Network
Blog
Feb 1, 2025, 17:30
Ph.D. pathways in cancer research: Miranda Reid - UF Health Cancer Center Cancer Training and Education Program
Blog
Feb 1, 2025, 17:27
ESMO - The latest advancements in the management of Lung Cancer
Blog
Feb 1, 2025, 17:24
Gregg Margolis: Three things to read about health policy this week
Blog
Feb 1, 2025, 17:20
David Planchard: Scientific exchange on lung cancer and conviviality at Gustave Roussy
Blog
Feb 1, 2025, 17:15
Lavondia Alexander: Grateful to Serve as Co-Chair of Atrium Health Wake Forest Baptist Cancer Center’s Advisory Board
Blog
Feb 1, 2025, 16:53
Honoring Satenik Safaryan’s Legacy at Yeolyan Hematology and Oncology Center - Pediatric Cancer and Blood Disorders Center of Armenia
Blog
Feb 1, 2025, 16:38
Iswanto Sucandy: Robotic right posterior sectionectomy for biliary cystadenoma
Blog
Feb 1, 2025, 16:32
Denis Horgan: EU Faces Crucial Turning Point in Healthcare Innovation
Blog
Feb 1, 2025, 16:23
What trials are you closely following that could impact the field in the next 5-10 years? - KidneyCAN
Science
Feb 1, 2025, 16:18
Randomized phase III trial of adjuvant carboplatin and paclitaxel in epithelial ovarian cancer